11/21
01:06 pm
mrna
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
11/21
09:44 am
mrna
Rating for MRNA
Medium
Report
Rating for MRNA
11/21
09:44 am
mrna
Rating for MRNA
Medium
Report
Rating for MRNA
11/21
09:34 am
mrna
Rating for MRNA
Medium
Report
Rating for MRNA
11/20
04:01 pm
mrna
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
Medium
Report
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
11/20
04:01 pm
mrna
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
Medium
Report
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
11/7
10:38 am
mrna
Rating for MRNA
Medium
Report
Rating for MRNA
11/7
10:38 am
mrna
Rating for MRNA
Medium
Report
Rating for MRNA
10/23
04:59 pm
mrna
Rating for MRNA
Low
Report
Rating for MRNA
10/23
12:17 pm
mrna
Rating for MRNA
Low
Report
Rating for MRNA
10/23
06:57 am
mrna
Rating for MRNA
Low
Report
Rating for MRNA
10/23
06:57 am
mrna
Rating for MRNA
Low
Report
Rating for MRNA
10/20
08:08 am
mrna
Moderna (NASDAQ:MRNA) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Medium
Report
Moderna (NASDAQ:MRNA) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
10/20
05:56 am
mrna
Rating for MRNA
Low
Report
Rating for MRNA
10/20
05:56 am
mrna
Rating for MRNA
Low
Report
Rating for MRNA
10/10
01:32 pm
mrna
Rating for MRNA
Low
Report
Rating for MRNA
10/10
01:32 pm
mrna
Rating for MRNA
Low
Report
Rating for MRNA